User menu

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.

Bibliographic reference Tarone, Guido ; Balligand, Jean-Luc ; Bauersachs, Johann ; Clerk, Angela ; De Windt, Leon ; et. al. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.. In: European journal of heart failure, Vol. 16, no.5, p. 494-508 (2014)
Permanent URL http://hdl.handle.net/2078.1/145677
  1. , McMurray John J.V., Adamopoulos Stamatis, Anker Stefan D., Auricchio Angelo, Böhm Michael, Dickstein Kenneth, Falk Volkmar, Filippatos Gerasimos, Fonseca Cândida, Gomez-Sanchez Miguel Angel, Jaarsma Tiny, Køber Lars, Lip Gregory Y.H., Maggioni Aldo Pietro, Parkhomenko Alexander, Pieske Burkert M., Popescu Bogdan A., Rønnevik Per K., Rutten Frans H., Schwitter Juerg, Seferovic Petar, Stepinska Janina, Trindade Pedro T., Voors Adriaan A., Zannad Faiez, Zeiher Andreas, Bax Jeroen J., Baumgartner Helmut, Ceconi Claudio, Dean Veronica, Deaton Christi, Fagard Robert, Funck-Brentano Christian, Hasdai David, Hoes Arno, Kirchhof Paulus, Knuuti Juhani, Kolh Philippe, McDonagh Theresa, Moulin Cyril, Popescu Bogdan A., Reiner Željko, Sechtem Udo, Sirnes Per Anton, Tendera Michal, Torbicki Adam, Vahanian Alec, Windecker Stephan, McDonagh Theresa, Sechtem Udo, Bonet Luis Almenar, Avraamides Panayiotis, Ben Lamin Hisham A., Brignole Michele, Coca Antonio, Cowburn Peter, Dargie Henry, Elliott Perry, Flachskampf Frank Arnold, Guida Guido Francesco, Hardman Suzanna, Iung Bernard, Merkely Bela, Mueller Christian, Nanas John N., Nielsen Olav Wendelboe, Ørn Stein, Parissis John T., Ponikowski Piotr, , , ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 : The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaborati, 10.1093/eurjhf/hfs105
  2. Ardehali Hossein, Sabbah Hani N., Burke Michael A., Sarma Satyam, Liu Peter P., Cleland John G.F., Maggioni Aldo, Fonarow Gregg C., Abel E. Dale, Campia Umberto, Gheorghiade Mihai, Targeting myocardial substrate metabolism in heart failure: potential for new therapies, 10.1093/eurjhf/hfr173
  3. Ciccarelli Michele, Santulli Gaetano, Pascale Valeria, Trimarco Bruno, Iaccarino Guido, Adrenergic receptors and metabolism: role in development of cardiovascular disease, 10.3389/fphys.2013.00265
  4. Ciccarelli M., Chuprun J. K., Rengo G., Gao E., Wei Z., Peroutka R. J., Gold J. I., Gumpert A., Chen M., Otis N. J., Dorn G. W., Trimarco B., Iaccarino G., Koch W. J., G Protein-Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance After Myocardial Ischemia, 10.1161/circulationaha.110.988642
  5. Thal D. M., Yeow R. Y., Schoenau C., Huber J., Tesmer J. J. G., Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors, 10.1124/mol.111.071522
  6. Ciccarelli Michele, Cipolletta Ersilia, Iaccarino Guido, GRK2 at the Control Shaft of Cellular Metabolism, 10.2174/138161212799040493
  7. Perino Alessia, Ghigo Alessandra, Ferrero Enrico, Morello Fulvio, Santulli Gaetano, Baillie George S., Damilano Federico, Dunlop Allan J., Pawson Catherine, Walser Romy, Levi Renzo, Altruda Fiorella, Silengo Lorenzo, Langeberg Lorene K., Neubauer Gitte, Heymans Stephane, Lembo Giuseppe, Wymann Matthias P., Wetzker Reinhard, Houslay Miles D., Iaccarino Guido, Scott John D., Hirsch Emilio, Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ, 10.1016/j.molcel.2011.01.030
  8. Ghigo A., Perino A., Mehel H., Zahradnikova A., Morello F., Leroy J., Nikolaev V. O., Damilano F., Cimino J., De Luca E., Richter W., Westenbroek R., Catterall W. A., Zhang J., Yan C., Conti M., Gomez A. M., Vandecasteele G., Hirsch E., Fischmeister R., Phosphoinositide 3-Kinase   Protects Against Catecholamine-Induced Ventricular Arrhythmia Through Protein Kinase A-Mediated Regulation of Distinct Phosphodiesterases, 10.1161/circulationaha.112.114074
  9. Naga Prasad Sathyamangla V., Esposito Giovanni, Mao Lan, Koch Walter J., Rockman Howard A., Gβγ-dependent Phosphoinositide 3-Kinase Activation in Hearts within VivoPressure Overload Hypertrophy, 10.1074/jbc.275.7.4693
  10. Naga Prasad Sathyamangla V., Jayatilleke Arundathi, Madamanchi Aasakiran, Rockman Howard A., Protein kinase activity of phosphoinositide 3-kinase regulates β-adrenergic receptor endocytosis, 10.1038/ncb1278
  11. Damilano F., Franco I., Perrino C., Schaefer K., Azzolino O., Carnevale D., Cifelli G., Carullo P., Ragona R., Ghigo A., Perino A., Lembo G., Hirsch E., Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase   Activity in Pressure Overload-Induced Cardiac Failure, 10.1161/circulationaha.110.950543
  12. Dessy C., Endothelial  3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization, 10.1161/01.cir.0000139331.85766.af
  13. Moniotte S., Kobzik L., Feron O., Trochu J.-N., Gauthier C., Balligand J.-L., Upregulation of  3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium, 10.1161/01.cir.103.12.1649
  14. Idigo Winifred O., Reilly Svetlana, Zhang Mei Hua, Zhang Yin Hua, Jayaram Raja, Carnicer Ricardo, Crabtree Mark J., Balligand Jean-Luc, Casadei Barbara, Regulation of Endothelial Nitric-oxide Synthase (NOS)S-Glutathionylation by Neuronal NOS : EVIDENCE OF A FUNCTIONAL INTERACTION BETWEEN MYOCARDIAL CONSTITUTIVE NOS ISOFORMS, 10.1074/jbc.m112.412031
  15. Belge, Circulation (2013)
  16. Dessy C., Endothelial  3-Adrenoreceptors Mediate Nitric Oxide-Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation  -Blocker Nebivolol, 10.1161/circulationaha.104.532960
  17. Flather M. D., Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), 10.1093/eurheartj/ehi115
  18. Sorrentino Sajoscha A., Doerries Carola, Manes Costantina, Speer Thimoteus, Dessy Chantal, Lobysheva Irina, Mohmand Wazma, Akbar Razma, Bahlmann Ferdinand, Besler Christian, Schaefer Arnd, Hilfiker-Kleiner Denise, Lüscher Thomas F., Balligand Jean-Luc, Drexler Helmut, Landmesser Ulf, Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade, 10.1016/j.jacc.2010.09.037
  19. Ozakca I., Arioglu-Inan E., Esfahani H., Altan V. M., Balligand J.-L., Kayki-Mutlu G., Ozcelikay A. T., Nebivolol prevents desensitization of  -adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond  1-adrenoceptor blockage, 10.1152/ajpheart.00352.2012
  20. Pokreisz P., Vandenwijngaert S., Bito V., Van den Bergh A., Lenaerts I., Busch C., Marsboom G., Gheysens O., Vermeersch P., Biesmans L., Liu X., Gillijns H., Pellens M., Van Lommel A., Buys E., Schoonjans L., Vanhaecke J., Verbeken E., Sipido K., Herijgers P., Bloch K. D., Janssens S. P., Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice, 10.1161/circulationaha.108.822072
  21. Lee D. I., Kass D. A., Phosphodiesterases and Cyclic GMP Regulation in Heart Muscle, 10.1152/physiol.00011.2012
  22. Guazzi M., Vicenzi M., Arena R., Guazzi M. D., PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure: Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study, 10.1161/circheartfailure.110.944694
  23. Redfield Margaret M., Chen Horng H., Borlaug Barry A., Semigran Marc J., Lee Kerry L., Lewis Gregory, LeWinter Martin M., Rouleau Jean L., Bull David A., Mann Douglas L., Deswal Anita, Stevenson Lynne W., Givertz Michael M., Ofili Elizabeth O., O’Connor Christopher M., Felker G. Michael, Goldsmith Steven R., Bart Bradley A., McNulty Steven E., Ibarra Jenny C., Lin Grace, Oh Jae K., Patel Manesh R., Kim Raymond J., Tracy Russell P., Velazquez Eric J., Anstrom Kevin J., Hernandez Adrian F., Mascette Alice M., Braunwald Eugene, RELAX Trial for the, Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction : A Randomized Clinical Trial, 10.1001/jama.2013.2024
  24. Zhang Yixuan, Tocchetti Carlo G., Krieg Thomas, Moens An L., Oxidative and nitrosative stress in the maintenance of myocardial function, 10.1016/j.freeradbiomed.2012.07.010
  25. Tocchetti Carlo G., Stanley Brian A., Murray Christopher I., Sivakumaran Vidhya, Donzelli Sonia, Mancardi Daniele, Pagliaro Pasquale, Gao Wei Dong, van Eyk Jennifer, Kass David A., Wink David A., Paolocci Nazareno, Playing with Cardiac “Redox Switches”: The “HNO Way” to Modulate Cardiac Function, 10.1089/ars.2010.3859
  26. Sabbah H. N., Tocchetti C. G., Wang M., Daya S., Gupta R. C., Tunin R. S., Mazhari R., Takimoto E., Paolocci N., Cowart D., Colucci W. S., Kass D. A., Nitroxyl (HNO): A Novel Approach for the Acute Treatment of Heart Failure, 10.1161/circheartfailure.113.000632
  27. Marks Andrew R., Calcium cycling proteins and heart failure: mechanisms and therapeutics, 10.1172/jci62834
  28. Hulot J-S, Senyei G, Hajjar R J, Sarcoplasmic reticulum and calcium cycling targeting by gene therapy, 10.1038/gt.2012.34
  29. Jessup M., Greenberg B., Mancini D., Cappola T., Pauly D. F., Jaski B., Yaroshinsky A., Zsebo K. M., Dittrich H., Hajjar R. J., , Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure, 10.1161/circulationaha.111.022889
  30. Malik F. I., Hartman J. J., Elias K. A., Morgan B. P., Rodriguez H., Brejc K., Anderson R. L., Sueoka S. H., Lee K. H., Finer J. T., Sakowicz R., Baliga R., Cox D. R., Garard M., Godinez G., Kawas R., Kraynack E., Lenzi D., Lu P. P., Muci A., Niu C., Qian X., Pierce D. W., Pokrovskii M., Suehiro I., Sylvester S., Tochimoto T., Valdez C., Wang W., Katori T., Kass D. A., Shen Y.-T., Vatner S. F., Morgans D. J., Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure, 10.1126/science.1200113
  31. Shen Y.-T., Malik F. I., Zhao X., Depre C., Dhar S. K., Abarzua P., Morgans D. J., Vatner S. F., Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart Failure, 10.1161/circheartfailure.109.930321
  32. Cleland John GF, Teerlink John R, Senior Roxy, Nifontov Evgeny M, Mc Murray John JV, Lang Chim C, Tsyrlin Vitaly A, Greenberg Barry H, Mayet Jamil, Francis Darrel P, Shaburishvili Tamaz, Monaghan Mark, Saltzberg Mitchell, Neyses Ludwig, Wasserman Scott M, Lee Jacqueline H, Saikali Khalil G, Clarke Cyril P, Goldman Jonathan H, Wolff Andrew A, Malik Fady I, The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial, 10.1016/s0140-6736(11)61126-4
  33. Thum T., Catalucci D., Bauersachs J., MicroRNAs: novel regulators in cardiac development and disease, 10.1093/cvr/cvn137
  34. Callis Thomas E., Pandya Kumar, Seok Hee Young, Tang Ru-Hang, Tatsuguchi Mariko, Huang Zhan-Peng, Chen Jian-Fu, Deng Zhongliang, Gunn Bronwyn, Shumate Janelle, Willis Monte S., Selzman Craig H., Wang Da-Zhi, MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice, 10.1172/jci36154
  35. Montgomery R. L., Hullinger T. G., Semus H. M., Dickinson B. A., Seto A. G., Lynch J. M., Stack C., Latimer P. A., Olson E. N., van Rooij E., Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure, 10.1161/circulationaha.111.030932
  36. da Costa Martins Paula A., Salic Kanita, Gladka Monika M., Armand Anne-Sophie, Leptidis Stefanos, el Azzouzi Hamid, Hansen Arne, Coenen-de Roo Christina J., Bierhuizen Marti F., van der Nagel Roel, van Kuik Joyce, de Weger Roel, de Bruin Alain, Condorelli Gianluigi, Arbones Maria L., Eschenhagen Thomas, De Windt Leon J., MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling, 10.1038/ncb2126
  37. Haghikia Arash, Missol-Kolka Ewa, Tsikas Dimitrios, Venturini Letizia, Brundiers Stephanie, Castoldi Mirko, Muckenthaler Martina U., Eder Matthias, Stapel Britta, Thum Thomas, Haghikia Aiden, Petrasch-Parwez Elisabeth, Drexler Helmut, Hilfiker-Kleiner Denise, Scherr Michaela, Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes, 10.1093/eurheartj/ehq369
  38. Ucar Ahmet, Gupta Shashi K., Fiedler Jan, Erikci Erdem, Kardasinski Michal, Batkai Sandor, Dangwal Seema, Kumarswamy Regalla, Bang Claudia, Holzmann Angelika, Remke Janet, Caprio Massimiliano, Jentzsch Claudia, Engelhardt Stefan, Geisendorf Sabine, Glas Carolina, Hofmann Thomas G., Nessling Michelle, Richter Karsten, Schiffer Mario, Carrier Lucie, Napp L. Christian, Bauersachs Johann, Chowdhury Kamal, Thum Thomas, The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy, 10.1038/ncomms2090
  39. Heymans S., Corsten M. F., Verhesen W., Carai P., van Leeuwen R. E. W., Custers K., Peters T., Hazebroek M., Stoger L., Wijnands E., Janssen B. J., Creemers E. E., Pinto Y. M., Grimm D., Schurmann N., Vigorito E., Thum T., Stassen F., Yin X., Mayr M., de Windt L. J., Lutgens E., Wouters K., de Winther M. P. J., Zacchigna S., Giacca M., van Bilsen M., Papageorgiou A.-P., Schroen B., Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure, 10.1161/circulationaha.112.001357
  40. Hullinger Thomas G., Montgomery Rusty L., Seto Anita G., Dickinson Brent A., Semus Hillary M., Lynch Joshua M., Dalby Christina M., Robinson Kathryn, Stack Christianna, Latimer Paul A., Hare Joshua M., Olson Eric N., van Rooij Eva, Inhibition of miR-15 Protects Against Cardiac Ischemic InjuryNovelty and Significance, 10.1161/circresaha.111.244442
  41. Whelan Russell S., Kaplinskiy Vladimir, Kitsis Richard N., Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance, 10.1146/annurev.physiol.010908.163111
  42. Kung G., Konstantinidis K., Kitsis R. N., Programmed Necrosis, Not Apoptosis, in the Heart, 10.1161/circresaha.110.225730
  43. Dickens Laura S., Powley Ian R., Hughes Michelle A., MacFarlane Marion, The ‘complexities’ of life and death: Death receptor signalling platforms, 10.1016/j.yexcr.2012.04.005
  44. Smith Christopher C.T., Yellon Derek M., Necroptosis, necrostatins and tissue injury, 10.1111/j.1582-4934.2011.01341.x
  45. Oerlemans Martinus I. F. J., Liu Jia, Arslan Fatih, Ouden Krista, Middelaar Ben J., Doevendans Pieter A., Sluijter Joost P. G., Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo, 10.1007/s00395-012-0270-8
  46. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway J B, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast G C, Degterev A, Yuan J, Vandenabeele P, Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models, 10.1038/cddis.2012.176
  47. Di Lisa, Biochim Biophys Acta, 2011, 1316 (1813)
  48. Hausenloy DJ, Boston-Griffiths EA, Yellon DM, Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent : CsA and cardioprotection, 10.1111/j.1476-5381.2011.01700.x
  49. Piot Christophe, Croisille Pierre, Staat Patrick, Thibault Hélène, Rioufol Gilles, Mewton Nathan, Elbelghiti Rachid, Cung Thien Tri, Bonnefoy Eric, Angoulvant Denis, Macia Christophe, Raczka Franck, Sportouch Catherine, Gahide Gerald, Finet Gérard, André-Fouët Xavier, Revel Didier, Kirkorian Gilbert, Monassier Jean-Pierre, Derumeaux Geneviève, Ovize Michel, Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction, 10.1056/nejmoa071142
  50. Eschenhagen Thomas, Force Thomas, Ewer Michael S., de Keulenaer Gilles W., Suter Thomas M., Anker Stefan D., Avkiran Metin, de Azambuja Evandro, Balligand Jean-Luc, Brutsaert Dirk L., Condorelli Gianluigi, Hansen Arne, Heymans Stephane, Hill Joseph A., Hirsch Emilio, Hilfiker-Kleiner Denise, Janssens Stefan, de Jong Steven, Neubauer Gitte, Pieske Burkert, Ponikowski Piotr, Pirmohamed Munir, Rauchhaus Mathias, Sawyer Douglas, Sugden Peter H., Wojta Johann, Zannad Faiez, Shah Ajay M., Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology, 10.1093/eurjhf/hfq213
  51. Liu Xifu, Gu Xinhua, Li Zhaoming, Li Xinyan, Li Hui, Chang Jianjie, Chen Ping, Jin Jing, Xi Bing, Chen Denghong, Lai Donna, Graham Robert M., Zhou Mingdong, Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy, 10.1016/j.jacc.2006.05.057
  52. Gao Runlin, Zhang Jian, Cheng Liuquan, Wu Xuesi, Dong Wei, Yang Xinchun, Li Tianchang, Liu Xifu, Xu Yabei, Li Xinyan, Zhou Mingdong, A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure, 10.1016/j.jacc.2009.12.044
  53. Jabbour Andrew, Hayward Christopher S., Keogh Anne M., Kotlyar Eugene, McCrohon Jane A., England John F., Amor Raul, Liu Xifu, Li Xin Yan, Zhou Ming Dong, Graham Robert M., Macdonald Peter S., Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses, 10.1093/eurjhf/hfq152
  54. Willis Monte S., Patterson Cam, Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?, 10.1056/nejmra1106180
  55. Rajasekaran Namakkal Soorappan, Varadharaj Saradhadevi, Khanderao Gayatri D., Davidson Christopher J., Kannan Sankaranarayanan, Firpo Matthew A., Zweier Jay L., Benjamin Ivor J., Sustained Activation of Nuclear Erythroid 2-Related Factor 2/Antioxidant Response Element Signaling Promotes Reductive Stress in the Human Mutant Protein Aggregation Cardiomyopathy in Mice, 10.1089/ars.2010.3587
  56. Kumarapeli A. R. K., Su H., Huang W., Tang M., Zheng H., Horak K. M., Li M., Wang X.,  B-Crystallin Suppresses Pressure Overload Cardiac Hypertrophy, 10.1161/circresaha.108.180117
  57. Fan Guo-Chang, Kranias Evangelia G., Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure, 10.1016/j.yjmcc.2010.09.013
  58. Danan Ilan J., Rashed Eman R., Depre Christophe, Therapeutic Potential of H11 Kinase for the Ischemic Heart : H11 KINASE, 10.1111/j.1527-3466.2007.00002.x
  59. Qiu H., Lizano P., Laure L., Sui X., Rashed E., Park J. Y., Hong C., Gao S., Holle E., Morin D., Dhar S. K., Wagner T., Berdeaux A., Tian B., Vatner S. F., Depre C., H11 Kinase/Heat Shock Protein 22 Deletion Impairs Both Nuclear and Mitochondrial Functions of STAT3 and Accelerates the Transition Into Heart Failure on Cardiac Overload, 10.1161/circulationaha.110.013847
  60. Ferretti Roberta, Sbroggiò Mauro, Di Savino Augusta, Fusella Federica, Bertero Alessandro, Michowski Wojciech, Tarone Guido, Brancaccio Mara, Morgana and melusin: Two fairies chaperoning signal transduction, 10.4161/cc.10.21.18202
  61. De Acetis M., Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload, 10.1161/01.res.0000168028.36081.e0
  62. Gamerdinger Martin, Carra Serena, Behl Christian, Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins, 10.1007/s00109-011-0795-6
  63. Arimura Takuro, Ishikawa Taisuke, Nunoda Shinichi, Kawai Sachio, Kimura Akinori, Dilated cardiomyopathy-associatedBAG3mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes, 10.1002/humu.21603
  64. Sakabe M., Shiroshita-Takeshita A., Maguy A., Brundel B. J.J.M., Fujiki A., Inoue H., Nattel S., Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia, 10.1093/cvr/cvn019
  65. Willis Monte S., Patterson Cam, Into the heart: The emerging role of the ubiquitin–proteasome system, 10.1016/j.yjmcc.2006.07.015
  66. Knoll, Circ Res, 109, 758 (2011)
  67. Li Wei, Bengtson Mario H., Ulbrich Axel, Matsuda Akio, Reddy Venkateshwar A., Orth Anthony, Chanda Sumit K., Batalov Serge, Joazeiro Claudio A. P., Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling, 10.1371/journal.pone.0001487
  68. Manning G., The Protein Kinase Complement of the Human Genome, 10.1126/science.1075762
  69. Rose B. A., Force T., Wang Y., Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale, 10.1152/physrev.00054.2009
  70. Soga Mayumi, Matsuzawa Atsushi, Ichijo Hidenori, Oxidative Stress-Induced Diseases via the ASK1 Signaling Pathway, 10.1155/2012/439587
  71. Cargnello M., Roux P. P., Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases, 10.1128/mmbr.00031-10
  72. Aye Thin Thin, Scholten Arjen, Taouatas Nadia, Varro Andras, Van Veen Toon A. B., Vos Marc A., Heck Albert J. R., Proteome-wide protein concentrations in the human heart, 10.1039/c004495d
  73. Delpire Eric, The mammalian family of sterile 20p-like protein kinases, 10.1007/s00424-009-0674-y
  74. Sheehan K. A., Ke Y., Solaro R. J., p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility, 10.1152/ajpregu.00253.2007
  75. Odashima M., Usui S., Takagi H., Hong C., Liu J., Yokota M., Sadoshima J., Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction, 10.1161/01.res.0000265846.23485.7a
  76. Mercier-Zuber Annie, OʼShaughnessy Kevin M., Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters : , 10.1097/mnh.0b013e3283484b06
  77. Fuller Stephen J., McGuffin Liam J., Marshall Andrew K., Giraldo Alejandro, Pikkarainen Sampsa, Clerk Angela, Sugden Peter H., A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3), 10.1042/bj20112000
  78. Sugden Peter H., McGuffin Liam J., Clerk Angela, SOcK, MiSTs, MASK and STicKs: the GCKIII (germinal centre kinase III) kinases and their heterologous protein–protein interactions, 10.1042/bj20130219
  79. Wagner Simona M., Sabourin Luc A., A novel role for the Ste20 kinase SLK in adhesion signaling and cell migration, 10.4161/cam.3.2.7229
  80. Franchini K.G., Focal adhesion kinase — The basis of local hypertrophic signaling domains, 10.1016/j.yjmcc.2011.06.021
  81. Koch Sina, Tugues Sònia, Li Xiujuan, Gualandi Laura, Claesson-Welsh Lena, Signal transduction by vascular endothelial growth factor receptors, 10.1042/bj20110301
  82. Ahn Anna, Frishman William H., Gutwein Andrew, Passeri Jonathan, Nelson Michael, Therapeutic Angiogenesis : A New Treatment Approach for Ischemic Heart Disease???Part I, 10.1097/crd.0b013e3181620e3b
  83. Hendel R. C., Henry T. D., Rocha-Singh K., Isner J. M., Kereiakes D. J., Giordano F. J., Simons M., Bonow R. O., Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial Perfusion : Evidence for a Dose-Dependent Effect, 10.1161/01.cir.101.2.118
  84. Henry T. D., The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis, 10.1161/01.cir.0000061911.47710.8a
  85. Rajagopalan Sanjay, Mohler Emile, Lederman Robert J, Saucedo Jorge, Mendelsohn Farrell O, Olin Jeffrey, Blebea John, Goldman Corey, Trachtenberg Jeffrey D, Pressler Milton, Rasmussen Henrik, Annex Brian H, Hirsch Alan T, Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial, 10.1016/s0002-8703(03)00102-9
  86. Pepe M., Mamdani M., Zentilin L., Csiszar A., Qanud K., Zacchigna S., Ungvari Z., Puligadda U., Moimas S., Xu X., Edwards J. G., Hintze T. H., Giacca M., Recchia F. A., Intramyocardial VEGF-B167 Gene Delivery Delays the Progression Towards Congestive Failure in Dogs With Pacing-Induced Dilated Cardiomyopathy, 10.1161/circresaha.110.220855
  87. Iwasaki Hiroto, Kawamoto Atsuhiko, Tjwa Marc, Horii Miki, Hayashi Saeko, Oyamada Akira, Matsumoto Tomoyuki, Suehiro Shigefumi, Carmeliet Peter, Asahara Takayuki, PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors, 10.1371/journal.pone.0024872
  88. Carnevale Daniela, Lembo Giuseppe, Placental Growth Factor and Cardiac Inflammation, 10.1016/j.tcm.2012.07.022
  89. Bry M., Kivela R., Holopainen T., Anisimov A., Tammela T., Soronen J., Silvola J., Saraste A., Jeltsch M., Korpisalo P., Carmeliet P., Lemstrom K. B., Shibuya M., Yla-Herttuala S., Alhonen L., Mervaala E., Andersson L. C., Knuuti J., Alitalo K., Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation, 10.1161/circulationaha.110.957332
  90. Wang Shusheng, Aurora Arin B., Johnson Brett A., Qi Xiaoxia, McAnally John, Hill Joseph A., Richardson James A., Bassel-Duby Rhonda, Olson Eric N., The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis, 10.1016/j.devcel.2008.07.002
  91. van Solingen Coen, Seghers Leonard, Bijkerk Roel, Duijs Jacques M.G.J., Roeten Marko K., van Oeveren-Rietdijk Annemarie M., Baelde Hans J., Monge Matthieu, Vos Joost B., de Boer Hetty C., Quax Paul H.A., Rabelink Ton J., Jan van Zonneveld Anton, Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis, 10.1111/j.1582-4934.2008.00613.x
  92. Hu S., Huang M., Li Z., Jia F., Ghosh Z., Lijkwan M. A., Fasanaro P., Sun N., Wang X., Martelli F., Robbins R. C., Wu J. C., MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease, 10.1161/circulationaha.109.928424
  93. Patten Ian S., Rana Sarosh, Shahul Sajid, Rowe Glenn C., Jang Cholsoon, Liu Laura, Hacker Michele R., Rhee Julie S., Mitchell John, Mahmood Feroze, Hess Philip, Farrell Caitlin, Koulisis Nicole, Khankin Eliyahu V., Burke Suzanne D., Tudorache Igor, Bauersachs Johann, Monte Federica del, Hilfiker-Kleiner Denise, Karumanchi S. Ananth, Arany Zoltan, Cardiac angiogenic imbalance leads to peripartum cardiomyopathy, 10.1038/nature11040
  94. Hilfiker-Kleiner Denise, Kaminski Karol, Podewski Edith, Bonda Tomasz, Schaefer Arnd, Sliwa Karen, Forster Olaf, Quint Anja, Landmesser Ulf, Doerries Carola, Luchtefeld Maren, Poli Valeria, Schneider Michael D., Balligand Jean-Luc, Desjardins Fanny, Ansari Aftab, Struman Ingrid, Nguyen Ngoc Q.N., Zschemisch Nils H., Klein Gunnar, Heusch Gerd, Schulz Rainer, Hilfiker Andres, Drexler Helmut, A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy, 10.1016/j.cell.2006.12.036
  95. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J. P., Becker A., McMurray J., Yamac H., Labidi S., Struman I., Hilfiker-Kleiner D., Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study, 10.1161/circulationaha.109.901496
  96. Halkein Julie, Tabruyn Sebastien P., Ricke-Hoch Melanie, Haghikia Arash, Nguyen Ngoc-Quynh-Nhu, Scherr Michaela, Castermans Karolien, Malvaux Ludovic, Lambert Vincent, Thiry Marc, Sliwa Karen, Noel Agnes, Martial Joseph A., Hilfiker-Kleiner Denise, Struman Ingrid, MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, 10.1172/jci64365
  97. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A. M., Dimmeler S., MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice, 10.1126/science.1174381
  98. Hinkel R., Penzkofer D., Zuhlke S., Fischer A., Husada W., Xu Q.-F., Baloch E., van Rooij E., Zeiher A. M., Kupatt C., Dimmeler S., Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model, 10.1161/circulationaha.113.001904
  99. Fiedler J., Jazbutyte V., Kirchmaier B. C., Gupta S. K., Lorenzen J., Hartmann D., Galuppo P., Kneitz S., Pena J. T. G., Sohn-Lee C., Loyer X., Soutschek J., Brand T., Tuschl T., Heineke J., Martin U., Schulte-Merker S., Ertl G., Engelhardt S., Bauersachs J., Thum T., MicroRNA-24 Regulates Vascularity After Myocardial Infarction, 10.1161/circulationaha.111.039008
  100. Hoch Melanie, Fischer Philipp, Stapel Britta, Missol-Kolka Ewa, Sekkali Belaid, Scherr Michaela, Favret Fabrice, Braun Thomas, Eder Matthias, Schuster-Gossler Karin, Gossler Achim, Hilfiker Andres, Balligand Jean-Luc, Drexler Helmut, Hilfiker-Kleiner Denise, Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies, 10.1016/j.stem.2011.07.001
  101. Horie Takahiro, Ono Koh, Nishi Hitoo, Nagao Kazuya, Kinoshita Minako, Watanabe Shin, Kuwabara Yasuhide, Nakashima Yasuhiro, Takanabe-Mori Rieko, Nishi Eiichiro, Hasegawa Koji, Kita Toru, Kimura Takeshi, Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway, 10.1093/cvr/cvq148
  102. Frangogiannis N. G., Matricellular Proteins in Cardiac Adaptation and Disease, 10.1152/physrev.00008.2011
  103. Weber Karl T., Sun Yao, Bhattacharya Syamal K., Ahokas Robert A., Gerling Ivan C., Myofibroblast-mediated mechanisms of pathological remodelling of the heart, 10.1038/nrcardio.2012.158
  104. Frolova E. G., Sopko N., Blech L., Popovic Z. B., Li J., Vasanji A., Drumm C., Krukovets I., Jain M. K., Penn M. S., Plow E. F., Stenina O. I., Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload, 10.1096/fj.11-190728
  105. Lynch Jeffrey M., Maillet Marjorie, Vanhoutte Davy, Schloemer Aryn, Sargent Michelle A., Blair N. Scott, Lynch Kaari A., Okada Tetsuya, Aronow Bruce J., Osinska Hanna, Prywes Ron, Lorenz John N., Mori Kazutoshi, Lawler Jack, Robbins Jeffrey, Molkentin Jeffery D., A Thrombospondin-Dependent Pathway for a Protective ER Stress Response, 10.1016/j.cell.2012.03.050
  106. Xie Jun, Wang Jingjing, Li Ruotian, Dai Qin, Yong Yonghong, Zong Bing, Xu Yunxia, Li Erguang, Ferro Albert, Xu Biao, Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction, 10.1016/j.yjmcc.2012.04.014
  107. Lopez B., Gonzalez A., Hermida N., Valencia F., de Teresa E., Diez J., Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects, 10.1152/ajpheart.00335.2010
  108. Lopez B., Querejeta R., Gonzalez A., Beaumont J., Larman M., Diez J., Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure, 10.1161/hypertensionaha.108.125278
  109. Group, Clin Ther, 201, 1204
  110. Thum Thomas, Gross Carina, Fiedler Jan, Fischer Thomas, Kissler Stephan, Bussen Markus, Galuppo Paolo, Just Steffen, Rottbauer Wolfgang, Frantz Stefan, Castoldi Mirco, Soutschek Jürgen, Koteliansky Victor, Rosenwald Andreas, Basson M. Albert, Licht Jonathan D., Pena John T. R., Rouhanifard Sara H., Muckenthaler Martina U., Tuschl Thomas, Martin Gail R., Bauersachs Johann, Engelhardt Stefan, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts, 10.1038/nature07511
  111. Adam Oliver, Löhfelm Björn, Thum Thomas, Gupta Shashi K., Puhl Sarah-Lena, Schäfers Hans-Joachim, Böhm Michael, Laufs Ulrich, Role of miR-21 in the pathogenesis of atrial fibrosis, 10.1007/s00395-012-0278-0
  112. Pan Z., Sun X., Shan H., Wang N., Wang J., Ren J., Feng S., Xie L., Lu C., Yuan Y., Zhang Y., Wang Y., Lu Y., Yang B., MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor- 1 Pathway, 10.1161/circulationaha.112.094524
  113. Salari K., Watkins H., Ashley E. A., Personalized medicine: hope or hype?, 10.1093/eurheartj/ehs112
  114. Talameh Jasmine A., McLeod Howard L., Adams Kirkwood F., Patterson J. Herbert, Genetic Tailoring of Pharmacotherapy in Heart Failure: Optimize the Old, While We Wait for Something New, 10.1016/j.cardfail.2012.01.002
  115. Jensen Brian C, McLeod Howard L, Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity, 10.2217/pgs.12.205
  116. Gao W. D., Murray C. I., Tian Y., Zhong X., DuMond J. F., Shen X., Stanley B. A., Foster D. B., Wink D. A., King S. B., Van Eyk J. E., Paolocci N., Nitroxyl-Mediated Disulfide Bond Formation Between Cardiac Myofilament Cysteines Enhances Contractile Function, 10.1161/circresaha.112.270827
  117. van Rooij E., Sutherland L. B., Qi X., Richardson J. A., Hill J., Olson E. N., Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA, 10.1126/science.1139089
  118. Gurusamy Narasimman, Lekli Istvan, Gherghiceanu Mihaela, Popescu Lawrence M., Das Dipak K., BAG-1 induces autophagy for cardiac cell survival, 10.4161/auto.5.1.7303
  119. Wang Xiaodan, Tokuda Haruhiko, Hatakeyama Daijiro, Hirade Kouseki, Niwa Masayuki, Ito Hidenori, Kato Kanefusa, Kozawa Osamu, Mechanism of simvastatin on induction of heat shock protein in osteoblasts, 10.1016/s0003-9861(03)00213-3
  120. Knoll R., Linke W. A., Zou P., Miocic S., Kostin S., Buyandelger B., Ku C.-H., Neef S., Bug M., Schafer K., Knoll G., Felkin L. E., Wessels J., Toischer K., Hagn F., Kessler H., Didie M., Quentin T., Maier L. S., Teucher N., Unsold B., Schmidt A., Birks E. J., Gunkel S., Lang P., Granzier H., Zimmermann W.-H., Field L. J., Faulkner G., Dobbelstein M., Barton P. J. R., Sattler M., Wilmanns M., Chien K. R., Telethonin Deficiency Is Associated With Maladaptation to Biomechanical Stress in the Mammalian Heart, 10.1161/circresaha.111.245787
  121. Ahn Anna, Frishman William H., Gutwein Andrew, Passeri Jonathan, Nelson Michael, Therapeutic Angiogenesis : A New Treatment Approach for Ischemic Heart Disease—Part II, 10.1097/crd.0b013e3181620e50
  122. Vanhoutte D., Schellings M. W.M., Gotte M., Swinnen M., Herias V., Wild M. K., Vestweber D., Chorianopoulos E., Cortes V., Rigotti A., Stepp M.-A., Van de Werf F., Carmeliet P., Pinto Y. M., Heymans S., Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction, 10.1161/circulationaha.106.644609
  123. Schellings Mark W.M., Vanhoutte Davy, Swinnen Melissa, Cleutjens Jack P., Debets Jacques, van Leeuwen Rick E.W., d'Hooge Jan, Van de Werf Frans, Carmeliet Peter, Pinto Yigal M., Sage E. Helene, Heymans Stephane, Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction, 10.1084/jem.20081244
  124. Cardin S., Guasch E., Luo X., Naud P., Le Quang K., Shi Y., Tardif J.-C., Comtois P., Nattel S., Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated With Experimental Postinfarction Heart Failure, 10.1161/circep.112.973214